Francesc Moncho's Avatar

Francesc Moncho

@fmoncho.bsky.social

Nephrologist at Hospital Clínico Universitario Valencia/ INCLIVA

350 Followers  |  58 Following  |  5 Posts  |  Joined: 18.11.2024  |  1.2902

Latest posts by fmoncho.bsky.social on Bluesky

Preview
Prospective evaluation of CAR-T cell therapy-related proteinuria and kidney dysfunction AbstractBackground. The nephrotoxicity of chimeric antigen receptor T-cell (CAR-T) therapy has been reported, yet data on urinary abnormalities remain limi

Our last work about proteinuria in CAR-T cell therapy. #nephjc #nephsky

academic.oup.com/ckj/advance-...

28.08.2025 17:38 — 👍 7    🔁 2    💬 1    📌 0
Post image

Sorry for the misunderstanding. I'm talking about the difference between the intensive care and the standard care arm, as well as the evidence of cardiovascular protection in diabetic patients with these drugs @hswapnil.bsky.social jamanetwork.com/journals/jam...

04.12.2024 17:00 — 👍 2    🔁 0    💬 1    📌 0

Sorry for joining late! Any thoughts on the impact of differences in ARBs and ACEi between groups on the primary outcome? #nephJC #nephsky

04.12.2024 07:07 — 👍 0    🔁 0    💬 1    📌 0
Preview
Semaglutide and kidney function: direct kidney protection or an artifact? - PubMed Semaglutide and kidney function: direct kidney protection or an artifact?

SMART trial try to adress that question by measuring GFR with iohexol, but only for 24w, where no differences were observed between groups in FLOW trial. A longer follow-up with GFR measurements will answer that question. #nephsky

23.11.2024 12:36 — 👍 2    🔁 0    💬 0    📌 0

I don’t like how the results of the trial have been expressed. Probably the best figure is number 3. I think we have to focus on patients other than 5 and 9 to understand whats happening with potassium.

#nephJC

20.11.2024 06:17 — 👍 1    🔁 0    💬 0    📌 0

@fmoncho is following 20 prominent accounts